ATE554776T1 - Antivirale phosphinatverbindungen - Google Patents
Antivirale phosphinatverbindungenInfo
- Publication number
- ATE554776T1 ATE554776T1 AT07796752T AT07796752T ATE554776T1 AT E554776 T1 ATE554776 T1 AT E554776T1 AT 07796752 T AT07796752 T AT 07796752T AT 07796752 T AT07796752 T AT 07796752T AT E554776 T1 ATE554776 T1 AT E554776T1
- Authority
- AT
- Austria
- Prior art keywords
- phosphinate compounds
- antiviral
- antiviral phosphinate
- compounds
- phosphinate
- Prior art date
Links
- 230000000840 anti-viral effect Effects 0.000 title 1
- ACVYVLVWPXVTIT-UHFFFAOYSA-M phosphinate Chemical class [O-][PH2]=O ACVYVLVWPXVTIT-UHFFFAOYSA-M 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US81948806P | 2006-07-07 | 2006-07-07 | |
| US83290806P | 2006-07-24 | 2006-07-24 | |
| PCT/US2007/015664 WO2008005565A2 (en) | 2006-07-07 | 2007-07-06 | Antiviral phosphinate compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE554776T1 true ATE554776T1 (de) | 2012-05-15 |
Family
ID=38626760
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07796752T ATE554776T1 (de) | 2006-07-07 | 2007-07-06 | Antivirale phosphinatverbindungen |
Country Status (20)
| Country | Link |
|---|---|
| US (4) | US7893264B2 (de) |
| EP (2) | EP2422791B1 (de) |
| JP (3) | JP2009542698A (de) |
| KR (1) | KR20090026216A (de) |
| CN (1) | CN102532198A (de) |
| AR (1) | AR061840A1 (de) |
| AT (1) | ATE554776T1 (de) |
| AU (1) | AU2007269567B2 (de) |
| BR (1) | BRPI0713961A2 (de) |
| CA (1) | CA2656356C (de) |
| EA (1) | EA018098B1 (de) |
| ES (2) | ES2531315T3 (de) |
| HK (1) | HK1127295A1 (de) |
| HR (1) | HRP20090076A2 (de) |
| IL (1) | IL195489A0 (de) |
| MX (1) | MX2009000236A (de) |
| NO (1) | NO20090596L (de) |
| TW (1) | TW200819460A (de) |
| WO (1) | WO2008005565A2 (de) |
| ZA (1) | ZA200810400B (de) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20090024834A (ko) * | 2006-07-05 | 2009-03-09 | 인터뮨, 인크. | Ｃ형 간염 바이러스 복제의 신규 억제제 |
| US7893264B2 (en) * | 2006-07-07 | 2011-02-22 | Gilead Sciences, Inc. | Antiviral phosphinate compounds |
| AU2009249443A1 (en) * | 2008-04-15 | 2009-11-26 | Intermune, Inc. | Novel macrocyclic inhibitors of hepatitis C virus replication |
| JP5690286B2 (ja) * | 2009-03-04 | 2015-03-25 | イデニク プハルマセウティカルス，インコーポレイテッド | ホスホチオフェン及びホスホチアゾールｈｃｖポリメラーゼ阻害剤 |
| UY32715A (es) * | 2009-06-23 | 2011-01-31 | Gilead Sciences Inc | Combinaciones farmacéuticas útiles para el tratamiento del virus de la hepatitis c (vhc), usos y métodos relacionados |
| US8476225B2 (en) | 2009-12-04 | 2013-07-02 | Gilead Sciences, Inc. | Antiviral compounds |
| US20110306541A1 (en) * | 2010-06-10 | 2011-12-15 | Gilead Sciences, Inc. | Methods for treating hcv |
| NZ613370A (en) | 2010-12-20 | 2015-05-29 | Gilead Sciences Inc | Combinations for treating hcv |
| US8957203B2 (en) | 2011-05-05 | 2015-02-17 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| US8691757B2 (en) | 2011-06-15 | 2014-04-08 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| DE202012013074U1 (de) | 2011-09-16 | 2014-10-29 | Gilead Pharmasset Lcc | Zusammensetzungen zur Behandlung von HCV |
| GB2506085A (en) | 2011-10-21 | 2014-03-19 | Abbvie Inc | Combination treatment (eg with ABT-072 or ABT-333) of DAAS for use in treating HCV |
| US8466159B2 (en) | 2011-10-21 | 2013-06-18 | Abbvie Inc. | Methods for treating HCV |
| US8492386B2 (en) | 2011-10-21 | 2013-07-23 | Abbvie Inc. | Methods for treating HCV |
| DE112012003510T5 (de) | 2011-10-21 | 2015-03-19 | Abbvie Inc. | Verfahren zur Behandlung von HCV umfassend mindestens zwei direkt wirkende antivirale Wirkstoffe, Ribavirin aber nicht Interferon |
| EA025560B1 (ru) | 2012-10-19 | 2017-01-30 | Бристол-Майерс Сквибб Компани | Ингибиторы вируса гепатита с |
| US9643999B2 (en) | 2012-11-02 | 2017-05-09 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| WO2014070964A1 (en) | 2012-11-02 | 2014-05-08 | Bristol-Myers Squibb Company | Hepatitis c virus inhibitors |
| EP2914598B1 (de) | 2012-11-02 | 2017-10-18 | Bristol-Myers Squibb Company | Inhibitoren des hepatitis-c-virus |
| EP2914614B1 (de) | 2012-11-05 | 2017-08-16 | Bristol-Myers Squibb Company | Inhibitoren des hepatitis-c-virus |
| SI2950786T1 (sl) | 2013-01-31 | 2020-03-31 | Gilead Pharmasset Llc | Formulacija kombinacije dveh protivirusnih spojin |
| CN105164148A (zh) | 2013-03-07 | 2015-12-16 | 百时美施贵宝公司 | 丙型肝炎病毒抑制剂 |
| CN103539831B (zh) * | 2013-09-29 | 2016-02-03 | 北京林业大学 | 山杏α-葡萄糖苷酶抑制肽及其制备方法和用途 |
| CN103539833B (zh) * | 2013-09-29 | 2016-02-03 | 北京林业大学 | 高活性α-葡萄糖苷酶抑制肽及其制备方法和用途 |
| JP7129703B2 (ja) | 2016-04-28 | 2022-09-02 | エモリー ユニバーシティー | アルキン含有ヌクレオチド及びヌクレオシド治療組成物並びにそれらに関連した使用 |
| US11738013B2 (en) | 2016-05-27 | 2023-08-29 | Gilead Sciences, Inc. | Methods for treating hepatitis B virus infections using NS5A, NS5B or NS3 inhibitors |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816570A (en) | 1982-11-30 | 1989-03-28 | The Board Of Regents Of The University Of Texas System | Biologically reversible phosphate and phosphonate protective groups |
| US4968788A (en) | 1986-04-04 | 1990-11-06 | Board Of Regents, The University Of Texas System | Biologically reversible phosphate and phosphonate protective gruops |
| DK0533833T3 (da) | 1990-06-13 | 1996-04-22 | Arnold Glazier | Phosphorprolægemidler |
| EP0481214B1 (de) | 1990-09-14 | 1998-06-24 | Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic | Wirkstoffvorläufer von Phosphonaten |
| DE4308096A1 (de) | 1993-03-13 | 1994-09-15 | Hoechst Ag | Prodrug-Derivate von Enzyminhibitoren mit Hydroxylgruppen, Verfahren zu deren Herstellung und ihre Verwendung |
| EP0632048B1 (de) | 1993-06-29 | 2001-03-21 | Mitsubishi Chemical Corporation | Phosphonat-Nukleotid Ester-Derivate |
| WO1995007920A1 (en) | 1993-09-17 | 1995-03-23 | Gilead Sciences, Inc. | Nucleotide analogs |
| JPH07183249A (ja) | 1993-12-22 | 1995-07-21 | Nec Yamagata Ltd | イオン注入工程管理方法 |
| US5543523A (en) | 1994-11-15 | 1996-08-06 | Regents Of The University Of Minnesota | Method and intermediates for the synthesis of korupensamines |
| US5968788A (en) * | 1995-08-28 | 1999-10-19 | Toray Industries, Inc. | Method for producing folic acid |
| US6004977A (en) * | 1996-12-27 | 1999-12-21 | Hoechst Marion Roussel, Inc. | N-(pyridinylamino) isoindolines and related compounds |
| DE19843360A1 (de) * | 1998-09-22 | 2000-03-30 | Hassan Jomaa | Phosphororganische Verbindungen und ihre Verwendung |
| US6828301B2 (en) * | 2002-02-07 | 2004-12-07 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions for hepatitis C viral protease inhibitors |
| WO2004094452A2 (en) | 2003-04-16 | 2004-11-04 | Bristol-Myers Squibb Company | Macrocyclic isoquinoline peptide inhibitors of hepatitis c virus |
| KR20070034119A (ko) * | 2004-07-16 | 2007-03-27 | 길리애드 사이언시즈, 인코포레이티드 | 항바이러스 화합물 |
| WO2007001406A2 (en) | 2004-10-05 | 2007-01-04 | Chiron Corporation | Aryl-containing macrocyclic compounds |
| ME02051B (me) * | 2005-04-13 | 2015-05-20 | Astex Therapeutics Ltd | Derivati hidroksibenzamida i njihova primena kao inhibitora hsp90 |
| CN102816170A (zh) | 2005-07-25 | 2012-12-12 | 因特蒙公司 | C型肝炎病毒复制的新颖大环抑制剂 |
| PE20070211A1 (es) * | 2005-07-29 | 2007-05-12 | Medivir Ab | Compuestos macrociclicos como inhibidores del virus de hepatitis c |
| CN101273027B (zh) * | 2005-07-29 | 2015-12-02 | 爱尔兰詹森科学公司 | 丙型肝炎病毒的大环抑制剂 |
| US7772183B2 (en) | 2005-10-12 | 2010-08-10 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| US7893264B2 (en) | 2006-07-07 | 2011-02-22 | Gilead Sciences, Inc. | Antiviral phosphinate compounds |
| US8293705B2 (en) * | 2007-12-21 | 2012-10-23 | Avila Therapeutics, Inc. | HCV protease inhibitors and uses thereof |
| UY32715A (es) | 2009-06-23 | 2011-01-31 | Gilead Sciences Inc | Combinaciones farmacéuticas útiles para el tratamiento del virus de la hepatitis c (vhc), usos y métodos relacionados |
| US8691757B2 (en) | 2011-06-15 | 2014-04-08 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
-
2007
- 2007-07-06 US US11/825,606 patent/US7893264B2/en active Active
- 2007-07-06 KR KR1020097002642A patent/KR20090026216A/ko not_active Application Discontinuation
- 2007-07-06 CA CA2656356A patent/CA2656356C/en not_active Expired - Fee Related
- 2007-07-06 WO PCT/US2007/015664 patent/WO2008005565A2/en active Application Filing
- 2007-07-06 ES ES11190674T patent/ES2531315T3/es active Active
- 2007-07-06 CN CN2011104294087A patent/CN102532198A/zh active Pending
- 2007-07-06 JP JP2009518397A patent/JP2009542698A/ja not_active Withdrawn
- 2007-07-06 AU AU2007269567A patent/AU2007269567B2/en not_active Ceased
- 2007-07-06 EP EP11190674.9A patent/EP2422791B1/de active Active
- 2007-07-06 AR ARP070103031A patent/AR061840A1/es not_active Application Discontinuation
- 2007-07-06 BR BRPI0713961-6A patent/BRPI0713961A2/pt not_active IP Right Cessation
- 2007-07-06 AT AT07796752T patent/ATE554776T1/de active
- 2007-07-06 US US12/303,219 patent/US20090227491A1/en not_active Abandoned
- 2007-07-06 ES ES07796752T patent/ES2388969T3/es active Active
- 2007-07-06 EA EA200900154A patent/EA018098B1/ru not_active IP Right Cessation
- 2007-07-06 TW TW096124722A patent/TW200819460A/zh unknown
- 2007-07-06 MX MX2009000236A patent/MX2009000236A/es active IP Right Grant
- 2007-07-06 EP EP07796752A patent/EP2043658B1/de active Active
-
2008
- 2008-11-25 IL IL195489A patent/IL195489A0/en unknown
- 2008-12-09 ZA ZA2008/10400A patent/ZA200810400B/en unknown
-
2009
- 2009-02-06 HR HR20090076A patent/HRP20090076A2/xx not_active Application Discontinuation
- 2009-02-06 NO NO20090596A patent/NO20090596L/no not_active Application Discontinuation
- 2009-07-16 HK HK09106472.5A patent/HK1127295A1/xx not_active IP Right Cessation
-
2010
- 2010-10-27 US US12/913,692 patent/US8674088B2/en active Active
- 2010-10-27 US US12/913,704 patent/US8586744B2/en active Active
-
2012
- 2012-02-28 JP JP2012041605A patent/JP2012107061A/ja not_active Withdrawn
-
2015
- 2015-01-22 JP JP2015010367A patent/JP6010640B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LTC2004635I2 (lt) | Pakeistieji enaminokarbonilo junginiai | |
| ATE554776T1 (de) | Antivirale phosphinatverbindungen | |
| ATE524477T1 (de) | Aziridinylepothilonverbindungen | |
| BRPI0815042A2 (pt) | Compostos de pirazol | |
| BRPI0813500A2 (pt) | Compostos antivirais | |
| BRPI0821086A2 (pt) | Compostos inseticidas | |
| BRPI0811264A2 (pt) | Compostos | |
| BRPI0720097A2 (pt) | Compostos de fosfonato | |
| BRPI0814424A2 (pt) | Compostos heterociclila | |
| DE602006016174D1 (de) | Blisterverpackungsverfahren | |
| CR10675A (es) | Analogos de 2-fenoxipirimidinona | |
| BRPI0809996A2 (pt) | Compostos | |
| FI20070846A0 (fi) | Releliitin | |
| DK1994062T3 (da) | Aryl/alkyl-vinylsulfonhyaluronsyrederivater | |
| BRPI0815181A2 (pt) | Compostos | |
| BRPI0814725A2 (pt) | Composição antiviral | |
| DE602006013286D1 (de) | Sicherheitseinrictung | |
| BRPI0814613A2 (pt) | Compostos | |
| CR10745A (es) | Analogos de pirazol | |
| BRPI0811860A2 (pt) | Compostos de (fenil)imidazolil)metilheteroarila | |
| DE602007010028D1 (de) | En | |
| TH94756B (th) | สารประกอบฟอสฟิเนทต้านไวรัส | |
| ZA201107393B (en) | Antiviral phosphinate compounds | |
| AP2008004721A0 (en) | Antiviral phosphinate compounds | |
| CR10205A (es) | Compuestos de cinamida policiclicos |